2. Forward looking statements;
Reconciliation and use of non-GAAP
measures to U.S. GAAP
This presentation may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues
or performance, capital expenditures, financing needs and other information that is not historical information. When used in this presentation, the words “outlook,”
“forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify
forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance
that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to
differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause
actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the
Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to
update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated
events or circumstances.
This presentation reflects three performance measures, operating EBITDA, adjusted earnings per share and adjusted free cash flow as non-U.S. GAAP measures.
The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating
profit; for adjusted earnings per share is earnings per common share-diluted; and for adjusted free cash flow is cash flow from operations.
►Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings
from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. We provide guidance on operating EBITDA
and are unable to reconcile forecasted operating EBITDA to a GAAP financial measure because a forecast of other charges and other adjustments is not practical.
Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting
processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an
alternative to operating profit as a measure of operating performance or to cash flow from operations as a measure of liquidity. Because not all companies use
identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating
EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest
payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.
►Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus
preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued
using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a
GAAP financial measure because a forecast of other charges and other adjustments is not practical. We believe that the presentation of this non-U.S. GAAP measure
provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations,
and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our
ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
►The tax rate used for adjusted earnings per share is the tax rate based on our original guidance communicated at the company’s investor day in December 2007.
We adjust this tax rate during the year only if there is a substantial change in our underlying operations; an updated forecast would not necessarily result in a change
to our tax rate used for adjusted earnings per share. The adjusted tax rate may differ significantly from the tax rate used for U.S. GAAP reporting in any given
reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any future period.
►Adjusted free cash flow is defined as cash flow from operations less capital expenditures, other productive asset purchases, operating cash from discontinued
operations and certain other charges. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors
regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to evaluate the company’s liquidity and assess credit
quality. This non-U.S. GAAP measure is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
2
3. Who is Celanese?
Superior Value Creation
Strategy
Industry Leader
Clear focus on growth and ►
value creation
Geographically balanced
●
global positions
Culture Diversified end market
Leading Global ●
Strong performance exposure
Integrated Producer
built on shared of Chemicals and
Strong Cash Generation
►
principles and
Advanced Materials
objectives
Significant Growth
►
Capability
Execution Track record of execution
●
Demonstrated track record
Clearly defined
●
of delivering results
opportunities
3
4. Today’s portfolio: higher growth, more
specialty
2007 Financial Highlights:
►
Operating EBITDA1
Net sales - $6,444 million
●
Operating EBITDA - $1,325 million
Advanced Engineered Materials ●
Consumer and Industrial Specialties
Strategic growth plans
►
Acetyl Intermediates
1,400
continue to accelerate
earnings of specialty
1,200
businesses
1,000
Essentially all growth has come from
●
$ in millions
specialty businesses
800
Two-thirds of 2010 Growth
●
Objectives expected from specialty
600
businesses
Resulting in:
400 ►
Higher growth rates
●
200
Increased overall earnings power of
●
the portfolio
-
Reduced volatility
●
2005 2006 2007
1Operating EBITDA excludes Other Activities of ($122), ($134) and ($82) respectively for the periods presented
4
5. Globally balanced and integrated
businesses aligned to accelerate growth
Differentiated Intermediates Specialty Products
Building Block
Acetate
Consumer
Specialties
Anhydride
(CS)
Nutrinova
and esters
Acetic
Acid
Emulsions
Industrial
Raw VAM PVOH Specialties
Materials
(IS)
AT Plastics
Formaldehyde
Ticona
Advanced
Engineering
Acetyl Intermediates Engineered
Polymers
(AI) Materials
(AEM)
Affiliates
5
6. Committed to delivering value creation
Primary Growth Focus
Balance Operational EBITDA
Group Asia Revitalization Innovation Organic
Sheet Excellence Impact
Consumer and
EPS Operating EBITDA
Industrial X X X X >$100MM
Specialties
Advanced
Engineered X X X X >$100MM
Materials
Acetyl
X X X >$100MM
Intermediates
Celanese Incremental
X X
Corporate EPS
$350 – $400 million increased EBITDA profile
plus EPS potential by 2010
6
7. On track and clear path forward to
accelerate 2010 Growth Objectives
Operating EBITDA Growth Objectives
Advanced Engineered Materials
400
AEM: volume growth > 2X GDP
Consumer and Industrial Specialties ►
Acetyl Intermediates
through further penetration
CIS: Acetate continues
►
$ in millions
execution on revitalization
200
strategy; Emulsions/PVOH
revitalization commences
AI: Nanjing acetic acid plant
►
startup leads integrated complex
0
2007 2008 2009 2010
7
8. AEM: value in technology and performance
realized in price and positioned for growth
$100 / kg Price for Performance
$10 / kg
$3 / kg
$100/kg
High-Performance Polymers (HPP)
5%
$10/kg
Engineering Thermoplastics (ETP)
$3/kg
others = 2%
Performance
Price Range
Ranges
PU = 6%
95% Standard Polymers
$1/ kg PET = 7%
ABS, SAN, ASA: 3%
PS, EPS = 8%
PVC = 17%
PE = 31% PP = 21%
$1/kg
Range of Products
8
9. AEM: significant opportunity for
increased penetration in high growth
region
Advanced Engineered Materials
Global Auto Production
Type of Resins
China
Japan
6
2001
U.S.
Germany
14
2007
India
S. Korea
2010E 18
China production
France
nearly doubles Highest
Brazil
within 5 years 40
Current
Spain Model
Canada 2006 Production China
2.5 Trend
Current
Production Growth 2006-2012
Mexico
0 3,000 6,000 9,000 12,000 15,000
Pounds per Vehicle
Vehicle Production (Thousand units)
Source: Global Insight Source: Celanese Estimates
9
10. AEM: megatrends driving growth for
Vectra® LCP through LED lighting
Customer
Requirements
High flow
►
Low emissions
►
Dimensional
►
stability
Pinpoint light
►
Drivers:
source
Improved safety
►
Lower energy consumption
►
$5.1 billion $17.4 billion
Miniaturization
►
Aesthetics
►
in 2006 in 2017
Design trends
►
Audi A8 Audi R8 LED Street Lamps Applying Connector
Daytime Running 54 LEDs per Expertise to New
Lights Headlamp Technologies
10 Source: Philips
11. IS: technology enhancements open
$1.0 billion of new growth opportunities
Global Vinyl Emulsions Applications Driving 2010 Growth
2010E
Growth
4.0
Applications Application
>25% Rate
Sales ($MM)
~30%
3.0
$ in billions
~25% Low VOC and nano
$400 – $500 10+%
increase in paints
2.0
vinyl space
Engineered
$200 – $300 3% - 5%
fabrics/glass fiber
1.0
Enviro-friendly
$100 – $200 8%
adhesives
0.0
2006 2010E China building/
$100 – $200 30+%
construction
Others
Celanese
$1.0 billion expansion = >$250 million in revenue
11
12. IS: current regulatory trends enabling
growth potential for VAE in U.S.
VOC Regulatory Trends for
European Interior Paint
European VAE Success Flat to Semi-Gloss Paints
Industry Development
50%
VAE Share of Interior
1999
US VOC grams/liter
EU VOC parts/liter
VOC (g/L): 250 – 380
Paints
VOC Content 2004
VOC (g/L): 100 – 150
0%
European
1996 2006 2010E
Standard
Celanese Others
1990 2006
1999 2008
Current trends in U.S. following European precedent
►
► In 2008, Southern California will further restrict emission requirements in paints
► Today, less than 25% of the interior paints meet the contemplated guidelines
$100 - $2001 per ton estimated cost for non-VAE emulsions to achieve standard
► U.S. interior paint opportunity ~$1.0 billion
VAE provides favorable substitution for low-VOC requirements
1 Based on Celanese estimates
12
13. AI: consumer trends support long-term
growth 1-2% greater than GDP
Acetyl Product
Key Trends End Market Increased Demand
Benefited
Paints, coatings, inks and adhesives
Emerging
VAM, Esters
used in residential and commercial
Economies
applications
Acetic Acid, Acetic
Demographics Pharmaceuticals
Anhydride
Increased demand for packaging films
Affluence VAM
(PVOH, EVOH)
Convenience Films and polyester Acetic Acid, VAM
Water Consumption of bottled water Acetic Acid
Environmentally friendly paints and
Environment VAM (for VAE)
coatings
13
14. AI: continued >GDP demand growth
driven by each major end use
Acetic Acid End-Use Growth
Annual acetic acid
►
(2000 – 2010)
demand growth of ~4.5%
through at least 2010
12,000 350
► Each end market is
China Acetic Acid Demand (indexed at 100)
experiencing favorable
CAGR 12%
Acetic Acid Demand by End-Use, kta
300
10,000
demand expansion
► 2007 – 2010 estimated
250
8,000
CAGR:
200
VAM: 6%
6,000
150
PTA: 7%
4,000
Esters: 4%
100
Anhydride: 3%
2,000
50
0 0
2000 2004 2007 2010
Strong acetic acid
VAM PTA Esters Anhydride Other China Demand
continues through 2010
Source: Tecnon and Celanese Estimates, 2008
14
15. AI: advantaged operating costs and
favorable supply/demand continues
through 2010
2010E Acetic Acid Cost Curve (kt)
Acetic Acid Supply/Demand Balance
(based on nameplate capacity)
High Cost
12,000
Ethylene Low Cost
High Cost Supply
Demand
Ethanol 10,000
8,000
Celanese
Conventional
Technology
kt
6,000
MeOH/CO
AOPlus™/Leading 4,000
Competition
2,000
By-
prod
0
2004 2005 2006 2007 2008E 2009E 2010E
Utilization of
0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 Effective
Capacity1(11/07 ): 91% 93% 92% 94% 93% 91% 91%
12008E-2010E effective utilization based on external analysis assumptions
Source: Celanese estimates, available public data
15
16. Recent initiatives to support growth
beyond 2010
Recent Actions
Direct to China
►
Announced plans to add polymer compounding
unit to the Nanjing Complex
Advanced
Commissioned start-up of Nanjing Celstran® unit
Engineered
Materials Kelsterbach relocation
►
Announced 40% capacity expansion at new
European POM facility
Signed an agreement with Wison to double
►
Nanjing CO supply increasing reliability and
supporting future expansion
Acetyl
Announced agreement with SWRI, a leading
Intermediates ►
Chinese technology institute, to acquire
technology licensing rights and development
capabilities
Recently announced authorization for $400 million share repurchase
16
17. Strong cash flow generation enables
future earnings growth
Adjusted Free Cash Flow1
Strong operating results
►
550 - 600
456
Working capital productivity
►
385
$ in millions
Decrease in overall borrowing
►
costs since 2005
Continued improvement in
►
interest coverage ratio
2006 2007 2008E
Enhanced capital flexibility
►
Operating EBITDA/Net Interest
Bias for growth spending
►
7x
8.0% Borrowing Rate
6.5x
6x
Maximize return to
►
6.1x
5x
shareholders
4.5x
4x
3.9x
3x
2x
6.9%
1x
0x
2005 2006 2007 2008E
1 Adjustedfree cash flow calculated as cash flow from operations less capital expenditures less other productive asset purchases less operating
17
cash from discontinued operations plus certain other charges – 2008 estimate excludes Kelsterbach relocation
18. Growth focused cash flow and capital
structure strategy
Cash Available for Strategic Use
Execute Growth Strategy Optimize Capital Structure
Cost Reduction
Core/Bolt-on Share Debt
& Revitalization Growth Projects Dividends
Acquisitions Repurchase Repayment
Projects
Capital Structure Objectives
Investment Criteria
Cost
Aligned with Strategic Pillars ►
►
Stability
2 – 4 year simple payback period ►
►
Flexibility
> 20 – 50% ROIC ►
►
Maximize shareholder value
►
18
19. Case for improved valuation
3Yr Avg EBITDA/Sales2
3Yr Avg FCF Yield2 3Yr Avg EBITDA Growth2
20% 20%
18%
15%
7%
14% 14%
14%
13%
5% 10%
5%
4%
4%
4%
2%
DOW PPG EMN ROH FMC CE -4%
-7%
DOW PPG EMN ROH FMC CE
DOW PPG EMN ROH FMC CE
NorthAvgEBITDAYield2 1 21
America Sales1
3Yr3YrForward % of Sales
3YrAvg % FCF Growth
Asia EBITDA/Sales
Avg of P/E2
66% 28%
12% 7%
20% 10%
15.8 20%
53% 52%
8% 18%
13.9
13.4 20%
45%
5% 45%
5%
15%
11.6 11.4
11.3
14% 14% 4%
4% 3% 15%
4% 14%
12% 28%
9%
-4%
-6%
North America % of Sales1
Asia % of Sales1
DOW PPG EMN ROH FMC CE
59% 28%
57%
25%
49%
22%
38% 37%
16%
29%
13%
11%
DOW PPG EMN ROH FMC CE
DOW PPG EMN ROH FMC CE
1Based on information provided in 2007 Form 10-K filings
2Thompson Financial as of April 30, 2008, Company reports, Celanese estimates
19
20. Well positioned for continued earnings
growth and value creation
Operating EBITDA Growth
Operating EBITDA Margin Operating EBITDA/Net Interest
Objectives
20% 400
19% 21%
19% 7x
20%
17% 6.5x
16% 6x
6.1x
15% 15% 19%
5x
15% 16% 17%
$ in millions
200 4.5x
4x
3.9x
10% 3x
11% 11% 11%
10%
2x
5%
0
1x
2000 2001 2002 2003 2004 2005 2006 2007
2007 2008 2009 2010
As Reported 0x
AI CIS AEM
2005 2006 2007 2008E
Pro Form a for Current Portfolio
Clear Growth
Improved Portfolio Increased Financial
Objectives
Performance Flexibility
Improved Shareholder Value
20
22. Delays continue to be common for
acetyl projects
Company Capacity 2005 2006 2007 2008 2009 2010
300kt
BP/FPC SU
A X
150kt
BP / Yaraco A X SU
200kt
Wujing A X X SU
150kt
Sopo A X SU
150kt
Fanavaran A X SU
200kt
Lunan Cathay X SU
A
500kt Cancelled
Acetex (Tasnee) A
600kt
Celanese Nanjing (Phase 1) X SU
A X
550kt
BP / Sinopec A X X X
425kt
Sipchem A X X X
200kt
Daqing A X SU
200kt
Hualu Hensheng X
A
350kt
Lunan Cathay (expansion) A X
600kt
Sopo (expansion) A X
200kt
Tianjin Bohei A X
Company announced startup CE 2005 update CE 2006 update CE 2007 update
A
X = Project delay SU = Actual plant startup
22
23. 2008 business outlook
(updated on April 22, 2008)
Volume growth >2x GDP across both transportation
►
and non-transportation applications
Advanced
► Continued high energy and raw material costs
Engineered
expected to pressure margins
2008 Guidance:
Materials
► Significant progress expected in Nanjing
production capabilities Adjusted EPS
$3.60 to $3.85
Synergy capture from APL integration
►
Consumer
► Strong underlying business fundamentals
Specialties
Operating EBITDA
High raw material costs continue
►
Industrial $1,355 to $1,415 million
► Realize benefits from revitalization efforts
Specialties
Forecasted 2008
Continued strong global demand
►
adjusted tax rate of
► Incremental acetic acid volume
26%
associated with China expansion
Acetyl
► VAM and acetic anhydride production scheduled to
Intermediates
begin in Nanjing
► Prices expected to adjust only modestly in 2008
23
24. Advanced Engineered Materials
in millions 1st Qtr 2008 1st Qtr 2007
Net Sales $262
$294 up 12%
Operating EBITDA $67
$60 down 10%
First Quarter 2008:
► Net sales increase driven by volume growth (6%) and positive
currency effects (8%)
► Growth in China continues to drive results
► Slight pricing declines due to geographic and product mix
► Higher raw material and energy costs continue to pressure margins
► Overall lower earnings from equity affiliates contributed to decrease
in Operating EBITDA
24
25. Consumer Specialties
in millions 1st Qtr 2008 1st Qtr 2007
Net Sales $269
$282 up 5%
Operating EBITDA $60
$65 up 8%
First Quarter 2008:
► Net sales increase primarily driven by European acquisition,
improved pricing on global demand and favorable currency impacts
► Pricing more than offset significantly higher energy costs
► Operating EBITDA improvement also includes acquisition synergies
25
26. Industrial Specialties
in millions 1st Qtr 2008 1st Qtr 2007
Net Sales $346
$365 up 5%
Operating EBITDA $26
$36 up 38%
First Quarter 2008:
► Increase in net sales primarily driven by favorable pricing and foreign
currency effects
► Volumes pressured by continued softness in U.S. housing and
construction segments
► Increased revenues offset raw material cost pressures
26
27. Acetyl Intermediates
1st Qtr 2008 1st Qtr 2007
in millions
Net Sales $839
$1,096 up 31%
Operating EBITDA $174
$246 up 41%
First Quarter 2008:
► Strong global demand sustained higher pricing levels and drove
record sales for the quarter
► Incremental volumes from the Nanjing plant also contributed to
increase
► Favorable supply/demand environment and increased dividends
from Ibn Sina more than offset higher raw material and energy
costs
27
28. Reg G: Reconciliation of Adjusted EPS
Adjusted Earnings Per Share - Reconciliation of a Non-U.S. GAAP Measure
Three Months Ended
March 31,
2008 2007
(in $ millions, except per share data)
Earnings from continuing operations
171
before tax and minority interests 218
Non-GAAP Adjustments:
1
Other charges and other adjustments 18
22
(2)
Refinancing costs -
Adjusted earnings from continuing operations
187
before tax and minority interests 240
2
Income tax provision on adjusted earnings (52)
(62)
-
Minority interests -
Adjusted earnings from continuing operations 178 135
Preferred dividends (2)
(3)
Adjusted net earnings available to common shareholders 175 133
Add back: Preferred dividends 2
3
Adjusted net earnings for adjusted EPS 178 135
Diluted shares (millions)
Weighted average shares outstanding 159.3
152.0
Assumed conversion of Preferred Shares 12.0
12.0
Assumed conversion of Restricted Stock -
0.5
3.1
Assumed conversion of stock options 2.8
Total diluted shares 174.4
167.3
Adjusted EPS $ 1.06 $ 0.77
1
See Table 7 for details
2
The adjusted tax rate for the three months ended March 31, 2008 is 26% based on the forecasted adjusted tax rate for 2008.
28
29. Reg G: Other Charges and Other
Adjustments
Other Charges and Other Adjustments
Other Charges:
Three Months Ended
March 31,
(in $ millions) 2008 2007
Employee termination benefits -
7
Plant/office closures -
7
Ticona Kelsterbach plant relocation -
2
1
Other -
Total 16 1
Other Adjustments: 1
Three Months Ended Income
March 31, Statement
Classification
(in $ millions) 2008 2007
Ethylene pipeline exit costs 10 Other income/expense, net
-
Business optimization 2 SG&A
9
Ticona Kelsterbach plant relocation - Cost of Sales
(2)
Other 5 Various
(1)
6 17
Total
22 18
Total other charges and other adjustments
1
These items are included in net earnings but not included in other charges.
29
30. Reg G: Other Charges and Other
Adjustments
Other Charges and Other Adjustments
Other Charges:
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2007 2006 2007 2006
Employee termination benefits 1 12
5 32
(1)
Plant/office closures (1) 11
7
Insurance recoveries associated with plumbing cases (2) (5)
(2) (4)
Insurance recoveries associated with Clear Lake, Texas - -
(40) (40)
Resolution of commercial disputes with a vendor - -
(31) (31)
Deferred compensation triggered by Exit Event - -
- 74
Asset impairments - -
- 9
Ticona Kelsterbach plant relocation - -
1 5
-
Other 4
- 2
Total (60) (2) 58 10
Other Adjustments: 1
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2007 2006 2007 2006
Executive severance & other costs related
to Squeeze-Out 2 30
- -
Ethylene pipeline exit costs - -
- 10
Business optimization 8 12
8 18
Foreign exchange loss related to refinancing transaction - -
- 22
Loss on AT Plastics films sale - -
- 7
2
Discontinued methanol production 16 52
- 31
Gain on disposal of investment (Pemeas) (11) (11)
- -
Gain on Edmonton sale - -
(34) (34)
Other 2 (1)
(7) 1
(33) 17 55 82
Total
(93) 15 113 92
Total other charges and other adjustments
1
These items are included in net earnings but not included in other charges.
2
Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company's 2007 guidance.
30
31. 31
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure
Three Months Ended
March 31,
(in $ millions) 2008 2007
Net Sales
294
Advanced Engineered Materials 262
282
Consumer Specialties 269
365
Industrial Specialties 346
EBITDA
1,096
Acetyl Intermediates 839
1
Other Activities - 1
(191)
Intersegment eliminations (162)
Total 1,846 1,555
Operating Profit (Loss)
30
Advanced Engineered Materials 36
50
Consumer Specialties 48
17
Industrial Specialties 12
177
Acetyl Intermediates 132
1
Other Activities (40) (22)
Total 234 206
Equity Earnings and Other Income/(Expense) 2
9
Advanced Engineered Materials 14
-
Consumer Specialties -
-
Industrial Specialties -
29
Acetyl Intermediates 5
1
Other Activities 4 4
Total 42 23
Other Charges and Other Adjustments 3
1
Advanced Engineered Materials -
1
Consumer Specialties 1
5
Industrial Specialties -
8
Acetyl Intermediates 13
1
Other Activities 7 4
Total 22 18
Depreciation and Amortization Expense
Reg G: Reconciliation of Operating
20
Advanced Engineered Materials 17
14
Consumer Specialties 11
14
Industrial Specialties 14
32
Acetyl Intermediates 24
1
Other Activities 2
3
Total 83 68
Operating EBITDA
60
Advanced Engineered Materials 67
65
Consumer Specialties 60
36
Industrial Specialties 26
246
Acetyl Intermediates 174
1
Other Activities (26) (12)
Total 381 315
1
Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies.
2
Includes equity earnings from affiliates, dividends from cost investments and other income/(expense).
3
Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).
32. 32
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure
Three Months Ended Twelve Months Ended
December 31, December 31,
(in $ millions) 2007 2006 2007 2006
Net Sales
253 1,030
Advanced Engineered Materials 224 915
279 1,111
Consumer Specialties 224 876
EBITDA
331 1,346
Industrial Specialties 309 1,281
1,083 3,615
Acetyl Intermediates 831 3,351
1
Other Activities - 2
6 22
(186) (660)
Intersegment eliminations (164) (667)
Total 1,760 1,430 6,444 5,778
Operating Profit (Loss)
30 133
Advanced Engineered Materials 29 145
69 199
Consumer Specialties 41 165
26 28
Industrial Specialties 9 44
276 616
Acetyl Intermediates 107 456
1
Other Activities (77) (228)
(46) (190)
Total 324 140 748 620
Equity Earnings and Other Income/(Expense) 2
7 55
Advanced Engineered Materials 13 55
3 40
Consumer Specialties 2 24
- -
Industrial Specialties - (1)
27 78
Acetyl Intermediates 23 63
1
Other Activities 8 -
12 22
Total 45 50 173 163
Other Charges and Other Adjustments 3
(10) (5)
Advanced Engineered Materials (1) (5)
(27) (16)
Consumer Specialties - -
(1) 32
Industrial Specialties 2 16
(97) (38)
Acetyl Intermediates 16 52
1
Other Activities 42 140
(2) 29
Total (93) 15 113 92
Depreciation and Amortization Expense
18 69
Advanced Engineered Materials 17 65
12 51
Consumer Specialties 10 39
Reg G: Reconciliation of Operating
16 59
Industrial Specialties 14 59
25 106
Acetyl Intermediates 23 101
1
Other Activities - 5
6
2
Total 73 64 291 269
Operating EBITDA
45 252
Advanced Engineered Materials 58 260
57 274
Consumer Specialties 53 228
41 119
Industrial Specialties 25 118
231 762
Acetyl Intermediates 169 672
1
Other Activities (25) (82)
(36) (134)
Total 349 269 1,325 1,144
1
Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies.
The 2007 Operating Profit (Loss) and Other Charges and Other Adjustments amounts include deductible associated with insurance recovery.
2
Includes equity earnings from affiliates, dividends from cost investments and other income/(expense).
3
Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).